H1 Inc., founded in 2017 and headquartered in New York City, is a global healthcare data technology company that specializes in providing data-driven insights to healthcare and pharmaceutical industries. The company helps these sectors identify and connect with healthcare professionals and key opinion leaders to accelerate drug development and medical research. Its platform is widely used by pharmaceutical giants such as Novartis and AstraZeneca.

The company was founded by Ariel Katz and Ian Sax under the original name H1 Insights. Since inception, it has expanded its offerings and client base steadily, accumulating over 400 employees and serving clients across more than 80 countries. It aims to create a more connected and efficient healthcare ecosystem by unlocking access to critical healthcare data.

H1’s strategic acquisitions, including the Portland-based startup Carevoyance and London-based Faculty Opinions, have enhanced its capabilities in medical research discovery and healthcare provider data integration. Faculty Opinions, for example, curates expert recommendations on the top 1% of biomedical literature, supporting high-quality medical insights derived from extensive biomedical research.

Committed to a user-centric and collaborative culture, H1 emphasizes values like starting with the user, valuing people, and fostering a unified team environment. This culture supports its mission to improve healthcare outcomes globally.

The company provides its services and products through an advanced healthcare data platform, facilitating partnerships and research engagements that drive the development of new treatments and therapies. Its goal is to democratize healthcare insights to benefit patients, researchers, and providers worldwide.

With over $305 million raised in funding, including investments from Menlo Ventures, Goldman Sachs Asset Management, and Novartis, H1 continues to innovate in the healthcare data space, shaping how medical knowledge and professional connections transform healthcare delivery and research.